Who invested in Medrobotics?
Medrobotics's investors include Hercules Capital.

United States · Funded startup
9 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Medrobotics and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$176Mraised across 9 rounds since 2011, from 9 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by MassdeviceSEC filing: $20M sold, first sale Jan 2017
No investor was named in the report.
From a historical funding recordSEC filing: $2.4M sold, first sale Sept 2015
No investor was named in the report.
From a historical funding recordSEC filing: $20M sold, first sale Oct 2014
No investor was named in the report.
From a historical funding record
No investor was named in the report.
Reported by sec.govSEC filing: $21M sold, first sale Sept 2013
No investor was named in the report.
Reported by bizjournals.comSEC filing: $8.1M sold, first sale Jul 2012
No investor was named in the report.
Reported by medrobotics.comSEC filing: $6.5M sold, first sale Dec 2011
Medrobotics filed 6 raises, $78M in all. Filings say how much was sold and to how many investors; they never name the investors.
From the SEC filings it signed: 7 on the team.
On the board, as filediBrad S. PetersenChristopher S. PetersenJames S. JordanRichard S. PetersenRobert S. BeckThomas S. Dugan
Medrobotics's investors include Hercules Capital.
Medrobotics has raised $176M across 9 rounds since 2011.
Medrobotics's most recent round was an Undisclosed round of $20M in Jan 2017.
Medrobotics's largest round on record is $34M (Series D), in Dec 2012.
Medrobotics's first round on record, in Mar 2013, was backed by Hercules Capital.
Medrobotics's latest named round is an Undisclosed round, in Jan 2017.
Medrobotics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.